John Pinching from PharmaTimes - Journalist Profile

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials - 6 days ago Actinogen boosts trial with Cambridge Cognition’s digital suite - 6 days ago Owlstone Medical announces $27 million USD first close in Series E financing round - 7 days ago Oxford Drug Design achieves in vivo validation for novel cancer treatment - 7 days ago Pheno Therapeutics granted trial authorisation for MS candidate - 8 days ago Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease - 8 days ago AI set to revolutionise pharmaceutical R&D says GlobalData - 9 days ago Gilead and LEO Pharma partner to develop oral STAT6 program - 9 days ago Cambridge Cognition highlights positive Cantab results - 14 days ago Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - 14 days ago Novartis gene therapy set to enhance SMA treatment - 15 days ago Merck unveils new cyber-physical trust platform at CES 2025 - 15 days ago New prostate cancer test cuts biopsies by 50% in US - 16 days ago Amgen’s lung cancer treatment gets conditional approval - 16 days ago NHS Confederation welcomes social care commission announcement - 19 days ago FDA approves Sequana Medical’s Alfapump for ascites treatment - 19 days ago EC approves Rybrevant with Lazcluze for advanced lung cancer - 20 days ago UK regulator warns against buying weight-loss medicines without prescription - 20 days ago MindMed begins phase 3 study of MM120 for anxiety disorder - about 1 month ago German cancer centre treats first patient with Elekta Evo - about 1 month ago CSL receives positive opinion for garadacimab in hereditary angioedema - about 1 month ago Beckley Psytech announces positive results for ELE-101 in depression trial - about 1 month ago Bayer begins inhibitor study treating advanced KRAS-mutated tumours - about 1 month ago Leriglitazone meets primary endpoint in pivotal cALD trial - about 1 month ago iOnctura achieves new clinical milestones in uveal melanoma therapy - about 1 month ago Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy - about 1 month ago Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - about 1 month ago CatalYm shows potential of visugromab for treating cachexia - about 1 month ago Imfinzi receives NICE recommendation for lung cancer treatment - about 1 month ago Poolbeg Pharma presents positive results for POLB 001 - about 1 month ago Teva’s Ajovy shows positive results in preventing pediatric migraines - about 2 months ago NICE endorses Neuraxpharm’s ublituximab for treating MS - about 2 months ago Antag Therapeutics secures €80 million in weight loss therapy financing - about 2 months ago Everest therapy shows promise in nephropathy trial - about 2 months ago KIMMTRAK recommended for funding by NICE for uveal melanoma patients - about 2 months ago Orbit Discovery and Evergreen Theragnostics expand research collaboration - about 2 months ago OGT launches enhanced genetic profiling panel for CLL - about 2 months ago Pharma giants vie for oral GLP-1R approval - about 2 months ago New injection offers hope for asthma and COPD attacks - about 2 months ago UK grants promising innovative medicine status to CIDP treatment - about 2 months ago Rab Prinjha - about 2 months ago God bless, Americas! - about 2 months ago Boids zone - about 2 months ago On message! - about 2 months ago Dr Lara Boyd - about 2 months ago Mikkel Wandahl Pedersen - about 2 months ago Osivax begins phase 2a booster trial for influenza vaccine - 2 months ago AC immune announces positive trial results for early Parkinson’s treatment - 2 months ago Microbiotica begins human trials for ulcerative colitis treatment - 2 months ago Vivolta and Neurochase to produce brain therapy catheters - 2 months ago
2	Urte Jakimaviciute PharmaTimes	AI set to revolutionise pharmaceutical R&D says GlobalData - 9 days ago
3	Christie Wong PharmaTimes	Novartis gene therapy set to enhance SMA treatment - 15 days ago